Ownership

13F as of Q2 2026 · 281.6M shares outstanding

Who owns VCRE?

By type of holder

Institutions 0.0% Everyone else 100.0%

No insider has reported a holding in the last two years, so insiders are counted in "Everyone else".

Institutional ownership

0.0%

0.0 pts vs last qtr

Institutional holders

0 vs last qtr

Net shares bought

by institutions in Q2 2026

New / sold out

0 / 0

positions opened vs closed

Institutions, last 8 quarters

No 13F manager has reported this stock in the last 8 quarters.

Biggest buyers in Q2 2026

None.

Biggest sellers in Q2 2026

None.

No insider has filed a notice of proposed sale (Form 144) for Vicore Pharma Holding AB in the last 12 months.

There are not yet two fiscal years of reported share counts for Vicore Pharma Holding AB.

No 13F manager reports holding VCRE.

Investment managers reporting VCRE on Form 13F

No 13F manager reports holding VCRE yet.

Mutual funds and ETFs reporting VCRE on Form N-PORT; together they hold 0.1% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
FB Franklin Biotechnology Discovery Fund Franklin Strategic Series	$1.43M	130.8K	0.05%	0.12%	July 31, 2026

Franklin Strategic Series

Position value

$1.43M

% of company

0.05%

% of the fund

0.12%

As of

July 31, 2026

Comments